Congressional Committee, SEC Probe ImClone’s Statements To Shareholders.
Venter Steps Down As Celera President; Moffitt, Puerto Rico Center Win NCI P20 Grant.
Susan Sieber, Former NCI Communications Chief, Dead.
Andrew von Eschenbach Sworn In As NCI Director.
Control-Arm CML Patients In Phase III Gleevec Study Allowed To Switch.
Amgen Agrees To Buy Immunex For $16 Billion In Stock And Cash.
FDA Approves Abbott’s HER-2 DNA Probe Kit.
Univ. Of Pittsburgh Plans Molecular Medicine Institute.
Trending Stories
- NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science - Trump administration is removing the mainstays of NCI and the federal government’s cancer program
Peer review, registries, and evidence-based patient information take a big hit - Bhattacharya cancels NIH all-hands meeting
- Cyber-iconoclast Vinay Prasad named head of FDA’s CBER
An oncologist, Prasad has criticized accelerated approval, next-gen sequencing, and targeted therapies - In the Headlines: “There’s no one to stand up for NCI right now.”
- George Weiner: Cancer centers are special, as are site visits in CCSG review